Immune-Onc Therapeutics
$7MTotal raised
Facts
as of Nov 22, 2026Charting a New Course in Immunology and Oncology Drug Development. Immunotherapy, which harnesses the body's own immune system to fight against disease, has changed the way we think about treatment — and even cures.
- Legal name
- Immune-Onc Therapeutics, Inc.
- Headquarters
- Palo Alto, United States
- Founded
- 2015
- Employees
- 2+US Form 5500 (plan participants) · Dec 2025 · -82% in a year
- Website
- immune-onc.com
These are the key facts about Immune-Onc Therapeutics on Alion as of Nov 22, 2026. Immune-Onc Therapeutics is headquartered in Palo Alto, United States. It was founded in 2015. The latest round is Venture - Series Unknown of $7M, announced in 2016.
Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake
Funding
Full ledger, 2 records →Immune-Onc Therapeutics has $7M paid in by investors, lenders and donors.
$7MPaid in
Money innewest first
$2.1MPaid
$7MPaid
Money by yearUSD, rounds and grants
Every row links its own source. A flow two sources state counts once; a figure a source does not state reads "not stated".
People
2+EmployeesUS Form 5500 (plan participants) · Dec 2025 · -82% in a year
Head countas filed and stated
Products
Products →Immune-Onc Therapeutics has 5 clinical trials on record, 1 under way.
Clinical trials
Dose Confirmation and Dose Expansion Phase 1 Study of IO-108 and IO-108 + Anti-PD-1 in Solid Tumors
phase 1 · completed · 38 participants · Advanced Solid Tumor
Sep 2022
Dose-Escalation and Dose-Expansion Study of IO-202 and IO-202+Pembrolizumab in Solid Tumors
phase 1 · completed · 22 participants · Solid Tumor, Adult
Apr 2022
First-in-human Study of IO-108 as Single Agent and in Combination With a PD-1 Immune Check Point Inhibitor in Patients …
phase 1 · completed · 91 participants · Solid Tumor, Adult
Sep 2021
Source: each app’s App Store and Google Play page (an app counts as the company’s when its developer site is on the company’s domain); the products its own site names.
Risk
Full record →Immune-Onc Therapeutics in public registers.
Legal entity active
Immune-Onc Therapeutics, Inc.
Not checked
No match
None
None
Patents
2
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices
Footprint
Hiring in 1 city in 1 country.
1Cities
1Countries
| Site | Type | Open roles | Hires most for | Engineering |
|---|---|---|---|---|
| Palo Alto United States | Headquarters | 0 |
Source: office addresses in postings and company registers
Milestones
2025
Team shrank to 2 was 11 · US Form 5500 (plan participants)
Aug 1, 2020
Won a grant $2.1M · CORDIS
Jul 1, 2016
Raised a round Venture round $7M · SEC Form D
2015
Founded
Each milestone is dated by its source: registers, filings, the press
